Article

Drug Target Identification in Triple Negative Breast Cancer Stem Cell Pathways: A Computational Study of Gene Regulatory Pathways Using Boolean Networks

2023-01-01

Abstract excerpt

Triple-negative breast cancer (TNBC) is an aggressive form of breast cancer associated with an early age of onset, greater propensity towards metastasis, and poorer clinical outcomes. It accounts for 10% to 20% of newly diagnosed breast cancer cases and disproportionately affects individuals from the African American race. While TNBC is sensitive to chemotherapy, it is also prone to relapse. This is because chemot...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3de9d80f-10b0-50a4-a737-6abf7ca8ded8
DOI: 10.1109/access.2023.3283291

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Drug Target Identification in Triple Negative Breast Cancer Stem Cell Pathways: A Computational Study of Gene Regulatory Pathways Using Boolean NetworksDOI 10.1109/access.2023.3283291Read

Drug Target Identification in Triple Negative Breast Cancer Stem Cell Pathways: a computational study of gene regulatory pathways using Boolean networksSemantic proximity Read

Gene expression profile analysis to discover molecular signatures for early diagnosis and therapies of triple-negative breast cancerSemantic proximity Read

Molecular pathways and therapeutic targets linked to triple-negative breast cancer (TNBC).Semantic proximity Read

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.Semantic proximity Read

Translational drugs targeting cancer stem cells in triple-negative breast cancerSemantic proximity Read

OPTIMIZING THERAPEUTIC TARGETS FOR BREAST CANCER USING BOOLEAN NETWORK MODELSSemantic proximity Read

Signaling pathways essential for triple-negative breast cancer stem-like cellsSemantic proximity Read

Identification of Therapeutic Gene Targets in Triple-Negative Breast Cancer: A Hybrid Approach Integrating Semidefinite Programming, Boolean Simulation, and Druggability AnalysisSemantic proximity Read

Identification of potential key genes and pathways predicting pathogenesis and prognosis for triple-negative breast cancerSemantic proximity Read

Identification of a Gene Panel Predictive of Triple-Negative Breast Cancer Response to Neoadjuvant Chemotherapy Employing Transcriptomic and Functional ValidationSemantic proximity Read

Precision Therapeutics in Triple-Negative Breast Cancer: Boolean Network Control and Pharmacological Mapping of Individualized ModelsSemantic proximity Read

An Insight Into the Cancer Stem Cell Survival Pathways Involved in Chemoresistance in Triple-Negative Breast CancerSemantic proximity Read